0 Comments
0 Shares
83 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Market Entry Barriers in the Pharmaceutical Robots Market Research LandscapeThe Pharmaceutical Robots Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 7.8 billion by 2034, registering a CAGR of 12.1%. The latest report, titled ‘Global Pharmaceutical Robots Market,’ comprises a profound analysis of the fundamental parameters contributing to the global Pharmaceutical Robots market scenario. The research report provides the...0 Comments 0 Shares 1K Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 8K Views 0 Reviews
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Comments 0 Shares 3K Views 0 Reviews
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comments 0 Shares 4K Views 0 Reviews1
-
Competitive Landscape of the Performance Enhancing Drugs MarketGrowing demand for endurance improvement solutions is influencing pharmaceutical development strategies.New drug delivery technologies are enhancing safety and efficacy.Expanding clinical trials are expected to create future growth opportunities. The Performance Enhancing Drugs Market The market is projected to grow at a CAGR of 7.2% from 2025 to 2031, with valuation expected to expand from US$...0 Comments 0 Shares 7K Views 0 Reviews
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Comments 0 Shares 3K Views 0 Reviews
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Comments 0 Shares 3K Views 0 Reviews
-
Global DXM and Codeine Syrup Market to Reach USD 2.75 Billion by 2034 Amid Rising Respiratory IllnessesAccording to a new report from Intel Market Research, the global DXM and Codeine Syrup market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a CAGR of 7.2% during the forecast period (2026-2034). This growth is driven by increasing respiratory illness prevalence, rising healthcare expenditure in emerging economies, and expanding...0 Comments 0 Shares 3K Views 0 Reviews
-
Global Gelatin Market to Reach USD 5.90 Billion by 2032 Driven by Pharma, Food, and Clean-Label DemandAccording to a new report from Intel Market Research, the global gelatin market was valued at USD 3.64 billion in 2024 and is projected to reach USD 5.90 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032). This growth is fueled by increasing demand across food & beverage, pharmaceutical, and cosmetic applications, coupled with gelatin's versatile functional...0 Comments 0 Shares 4K Views 0 Reviews
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Comments 0 Shares 4K Views 0 Reviews
-
Global Pirfenidone Tablets Market to Reach USD 2.08 Billion by 2034 Amid Rising IPF CasesAccording to a new report from Intel Market Research, the global Pirfenidone Tablets market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.08 billion by 2034, growing at a strong CAGR of 7.8% during the forecast period (2026–2034). This growth is driven by increasing prevalence of idiopathic pulmonary fibrosis (IPF), expanding geriatric population, and improved...0 Comments 0 Shares 3K Views 0 Reviews
-
Global Recombinant Human Insulin Market to Reach USD 9.7 Billion by 2034 Amid Rising Diabetes BurdenAccording to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.7 billion by 2034, growing at a CAGR of 5.6% during the forecast period (2026–2034). This sustained growth reflects the increasing global burden of diabetes and the shift toward biotechnology-derived insulin therapies that...0 Comments 0 Shares 3K Views 0 Reviews
-
Global Romiplostim Market to Reach USD 2.75 Billion by 2034 Driven by Rising ITP CasesAccording to a new report from Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2026-2034). This growth trajectory reflects the rising global burden of chronic immune thrombocytopenia (ITP) and increasing adoption of targeted biologic...0 Comments 0 Shares 2K Views 0 Reviews
More Results